EXPERT ENDORSED Investors ConcertAI is Backed by Investors Committed to Innovation in Life Sciences and Healthcare Our investors are committed to our continued growth and innovation in RWD and technology products and services for regulatory and non-regulatory applications, expansion into adjacent therapy areas, and commercial patient solutions. SymphonyAI Group SymphonyAI Group is the fastest-growing private group of B2B AI companies, backed by a $1 billion commitment to deliver next-generation AI solutions for transforming the enterprise. Since its founding in 2017, SymphonyAI Group has grown rapidly to a group of six companies with a combined revenue run rate approaching $300 million. Over 1,600 talented leaders, data scientists, and other professionals operate the group under the leadership of Dr. Romesh Wadhwani, one of Silicon Valley’s most successful serial entrepreneurs. Learn More Declaration Partners Declaration Partners is the investment firm backed by the family office of David M. Rubenstein, the Co-Founder of The Carlyle Group. Declaration Partners makes direct private equity and real estate investments, including building platform businesses, providing growth equity capital, seeding early stage private funds and venture studios, and partnering with family-owned businesses. Maverick Ventures Maverick Ventures is the venture arm of Maverick Capital, an investment firm managing more than $10 billion. Combining the resources of a global firm with the benefits of an agile, focused team, Maverick Ventures supports entrepreneurs through an evergreen structure from seed through maturity. With over 25 years of early-stage investment experience, the Maverick Ventures team has funded more than 80 companies in the healthcare, software and deep technology sectors. Learn More AllianceBernstein PCI AB Private Credit Investors is the middle market direct lending platform of AllianceBernstein L.P (AB). AB-PCI manages approximately $9.2 billion in capital available for investment and offers a range of financing solutions to middle market companies, including having the capacity to invest up to $150 million of credit to a single borrower while also making sizeable growth equity investments. The investment in ConcertAI was executed as part of AB-PCI’s Growth Stage Capital initiative (AB-GSC). AB-GSC caters to high growth technology companies backed by leading venture capital and growth equity firms. Other recent AB-GSC investments include companies such as Rubrik, Workfront, Degreed, Fuze and DataRobot. Learn More ConcertAI is delivering significant customer value today and is poised to drive substantial AI innovation in healthcare and life sciences. — DR. ROMESH WADHWANI, FOUNDER, CHAIRMAN AND CEO, SYMPHONYAI GROUP We are impressed with ConcertAI’s innovative culture, technology and leadership. ConcertAI is positioned to empower next-generation clinical research, accelerate breakthrough therapies and improve patient outcomes. — ANDREW GOLDFARB, PARTNER, DECLARATION PARTNERS Use Cases Commercial Solutions Study Design Regulatory Use External Control Arms AML Bladder Breast Gastric-Esophageal Lung Liver Melanoma Pancreatic Prostate Renal All Other Cancers Products & Services Data Products Predictive Patient STAR SPRINT Services Research Publications ERACE Resources Content Webinars and Events News Blog About Us Our Team Careers Investors Contact Us Request a Demo © 2017-2021 ConcertAI. All Rights Reserved. ConcertAI is a SymphonyAI company. Privacy Policy Terms of Use Privacy Policy Accept